생물정신의학 (Korean Journal of Biological Psychiatry)

  • 제25권4호
  • /
  • Pages.101-109
  • /
  • 2018
  • /
  • 1225-8709(pISSN)
  • /
  • 2005-7571(eISSN)
대한생물정신의학회 (The Korean Society of Biological Psychiatry)
권호 표지

한국인 조현병 환자에서 Chromogranin B 유전자와 안구운동 이상의 연합에 대한 연구

Association Analysis between Chromogranin B Genetic Variations and Smooth Pursuit Eye Movement Abnormality in Korean Patients with Schizophrenia

  • 박진완 (순천향대학교 의과대학 순천향대학교병원 정신건강의학교실) ;
  • 백두현 (순천향대학교 의과대학 순천향대학교병원 정신건강의학교실) ;
  • 황민규 (순천향대학교 의과대학 순천향대학교병원 정신건강의학교실) ;
  • 이민지 (순천향대학교 의과대학 순천향대학교병원 정신건강의학교실) ;
  • 신형두 (서강대학교 생명공학과) ;
  • 신태민 (연세대학교 의공학과) ;
  • 한상우 (순천향대학교 의과대학 순천향대학교병원 정신건강의학교실) ;
  • 황재욱 (순천향대학교 의과대학 순천향대학교병원 정신건강의학교실) ;
  • 이연정 (순천향대학교 의과대학 순천향대학교병원 정신건강의학교실) ;
  • 우성일 (순천향대학교 의과대학 순천향대학교병원 정신건강의학교실)
  • Park, Jin Wan (Department of Psychiatry, Soonchunhyang University Seoul Hospital, College of Medicine, Soonchunhyang University) ;
  • Pak, Doo Hyun (Department of Psychiatry, Soonchunhyang University Seoul Hospital, College of Medicine, Soonchunhyang University) ;
  • Hwang, Min Gyu (Department of Psychiatry, Soonchunhyang University Seoul Hospital, College of Medicine, Soonchunhyang University) ;
  • Lee, Min Ji (Department of Psychiatry, Soonchunhyang University Seoul Hospital, College of Medicine, Soonchunhyang University) ;
  • Shin, Hyoung Doo (Department of Life Science, Sogang University) ;
  • Shin, Tae-Min (Department of Biomedical Engineering, Yonsei University) ;
  • Hahn, Sang Woo (Department of Psychiatry, Soonchunhyang University Seoul Hospital, College of Medicine, Soonchunhyang University) ;
  • Hwang, Jaeuk (Department of Psychiatry, Soonchunhyang University Seoul Hospital, College of Medicine, Soonchunhyang University) ;
  • Lee, Yeon Jung (Department of Psychiatry, Soonchunhyang University Seoul Hospital, College of Medicine, Soonchunhyang University) ;
  • Woo, Sung-Il (Department of Psychiatry, Soonchunhyang University Seoul Hospital, College of Medicine, Soonchunhyang University)
  • 투고 : 2018.06.14
  • 심사 : 2018.08.23
  • 발행 : 2018.11.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Objectives According to previous studies, the Chromogranin B (CHGB) gene could be an important candidate gene for schizophrenia which is located on chromosome 20p12.3. Some studies have linked the polymorphism in CHGB gene with the risk of schizophrenia. Meanwhile, smooth pursuit eye movement (SPEM) abnormality has been regarded as one of the most consistent endophenotype of schizophrenia. In this study, we investigated the association between the polymorphisms in CHGB gene and SPEM abnormality in Korean patients with schizophrenia. Methods We measured SPEM function in 24 Korean patients with schizophrenia (16 male, 8 female) and they were divided according to SPEM function into two groups, good and poor SPEM function groups. We also investigated genotypes of polymorphisms in CHGB gene in each group. A logistic regression analysis was performed to find the association between SPEM abnormality and the number of polymorphism. Results The natural logarithm value of signal/noise ratio (Ln S/N ratio) of good SPEM function group was $4.19{\pm}0.19$ and that of poor SPEM function group was $3.17{\pm}0.65$. In total, 15 single nucleotide polymorphisms of CHGB were identified and the genotypes were divided into C/C, C/R, and R/R. Statistical analysis revealed that two genetic variants (rs16991480, rs76791154) were associated with SPEM abnormality in schizophrenia (p = 0.004). Conclusions Despite the limitations including a small number of samples and lack of functional study, our results suggest that genetic variants of CHGB may be associated with SPEM abnormality and provide useful preliminary information for further study.nwhile, smooth pursuit eye movement (SPEM) abnormality has been regarded as one of the most consistent endophenotype of schizophrenia. In this study, we investigated the association between the polymorphisms in CHGB gene and SPEM abnormality in Korean patients with schizophrenia. MethodsZZWe measured SPEM function in 24 Korean patients with schizophrenia (16 male, 8 female) and they were divided according to SPEM function into two groups, good and poor SPEM function groups. We also investigated genotypes of polymorphisms in CHGB gene in each group. A logistic regression analysis was performed to find the association between SPEM abnormality and the number of polymorphism. ResultsZZThe natural logarithm value of signal/noise ratio (Ln S/N ratio) of good SPEM function group was $4.19{\pm}0.19$ and that of poor SPEM function group was $3.17{\pm}0.65$. In total, 15 single nucleotide polymorphisms of CHGB were identified and the genotypes were divided into C/C, C/R, and R/R. Statistical analysis revealed that two genetic variants (rs16991480, rs76791154) were associated with SPEM abnormality in schizophrenia (p = 0.004). ConclusionsZZDespite the limitations including a small number of samples and lack of functional study, our results suggest that genetic variants of CHGB may be associated with SPEM abnormality and provide useful preliminary information for further study.

키워드

참고문헌

  1. Picchioni MM, Murray RM. Schizophrenia. BMJ 2007;335:91-95.
  2. van Os J, Kapur S. Schizophrenia. Lancet 2009;374:635-645. https://doi.org/10.1016/S0140-6736(09)60995-8
  3. Owen MJ, Craddock N, O'Donovan MC. Schizophrenia: genes at last? Trends Genet 2005;21:518-525. https://doi.org/10.1016/j.tig.2005.06.011
  4. Karayiorgou M, Gogos JA. A turning point in schizophrenia genetics. Neuron 1997;19:967-979. https://doi.org/10.1016/S0896-6273(00)80390-6
  5. Doherty JL, O'Donovan MC, Owen MJ. Recent genomic advances in schizophrenia. Clin Genet 2012;81:103-109. https://doi.org/10.1111/j.1399-0004.2011.01773.x
  6. Kim LH, Park BL, Cheong HS, Namgoong S, Kim JO, Kim JH, et al. Genome-wide association study with the risk of schizophrenia in a Korean population. Am J Med Genet B Neuropsychiatr Genet 2016;171B:257-265.
  7. Chen XW, Feng YQ, Hao CJ, Guo XL, He X, Zhou ZY, et al. DTNBP1, a schizophrenia susceptibility gene, affects kinetics of transmitter release. J Cell Biol 2008;181:791-801. https://doi.org/10.1083/jcb.200711021
  8. Gamo NJ, Duque A, Paspalas CD, Kata A, Fine R, Boven L, et al. Role of disrupted in schizophrenia 1 (DISC1) in stress-induced prefrontal cognitive dysfunction. Transl Psychiatry 2013;3:e328. https://doi.org/10.1038/tp.2013.104
  9. Harrison PJ, Law AJ. Neuregulin 1 and schizophrenia: genetics, gene expression, and neurobiology. Biol Psychiatry 2006;60:132-140. https://doi.org/10.1016/j.biopsych.2005.11.002
  10. Iijima Y, Inada T, Ohtsuki T, Senoo H, Nakatani M, Arinami T. Association between chromogranin b gene polymorphisms and schizophrenia in the Japanese population. Biol Psychiatry 2004;56:10-17. https://doi.org/10.1016/j.biopsych.2004.03.012
  11. Wu S, Ma J, Xing Q, Xu Y, Meng J, Cao D, et al. Further evidence that the chromogranin B gene confers predisposition to schizophrenia: a family-based association study in Chinese. J Neural Transm (Vienna) 2007;114:641-644. https://doi.org/10.1007/s00702-006-0600-9
  12. Zhang B, Tan Z, Zhang C, Shi Y, Lin Z, Gu N, et al. Polymorphisms of chromogranin B gene associated with schizophrenia in Chinese Han population. Neurosci Lett 2002;323:229-233. https://doi.org/10.1016/S0304-3940(02)00145-3
  13. Shin JG, Kim JH, Park CS, Kim BJ, Kim JW, Choi IG, et al. Genderspecific associations between CHGB genetic variants and schizophrenia in a Korean population. Yonsei Med J 2017;58:619-625. https://doi.org/10.3349/ymj.2017.58.3.619
  14. Taupenot L, Harper KL, O'Connor DT. The chromogranin-secretogranin family. N Engl J Med 2003;348:1134-1149. https://doi.org/10.1056/NEJMra021405
  15. Arnold SE, Trojanowski JQ. Recent advances in defining the neuropathology of schizophrenia. Acta Neuropathol 1996;92:217-231. https://doi.org/10.1007/s004010050512
  16. Selemon LD, Goldman-Rakic PS. The reduced neuropil hypothesis: a circuit based model of schizophrenia. Biol Psychiatry 1999;45:17-25. https://doi.org/10.1016/S0006-3223(98)00281-9
  17. Weinberger DR. Cell biology of the hippocampal formation in schizophrenia. Biol Psychiatry 1999;45:395-402. https://doi.org/10.1016/S0006-3223(98)00331-X
  18. Davidsson P, Gottfries J, Bogdanovic N, Ekman R, Karlsson I, Gottfries CG, et al. The synaptic-vesicle-specific proteins rab3a and synaptophysin are reduced in thalamus and related cortical brain regions in schizophrenic brains. Schizophr Res 1999;40:23-29. https://doi.org/10.1016/S0920-9964(99)00037-7
  19. Eastwood SL, Burnet PW, Harrison PJ. Altered synaptophysin expression as a marker of synaptic pathology in schizophrenia. Neuroscience 1995;66:309-319. https://doi.org/10.1016/0306-4522(94)00586-T
  20. Nowakowski C, Kaufmann WA, Adlassnig C, Maier H, Salimi K, Jellinger KA, et al. Reduction of chromogranin B-like immunoreactivity in distinct subregions of the hippocampus from individuals with schizophrenia. Schizophr Res 2002;58:43-53. https://doi.org/10.1016/S0920-9964(01)00389-9
  21. Landen M, Grenfeldt B, Davidsson P, Stridsberg M, Regland B, Gottfries CG, et al. Reduction of chromogranin A and B but not C in the cerebrospinal fluid in subjects with schizophrenia. Eur Neuropsychopharmacol 1999;9:311-315.
  22. Krauzlis RJ. The control of voluntary eye movements: new perspectives. Neuroscientist 2005;11:124-137. https://doi.org/10.1177/1073858404271196
  23. Lencer R, Trillenberg P. Neurophysiology and neuroanatomy of smooth pursuit in humans. Brain Cogn 2008;68:219-228. https://doi.org/10.1016/j.bandc.2008.08.013
  24. Lencer R, Sprenger A, Reilly JL, McDowell JE, Rubin LH, Badner JA, et al. Pursuit eye movements as an intermediate phenotype across psychotic disorders: evidence from the B-SNIP study. Schizophr Res 2015;169:326-333. https://doi.org/10.1016/j.schres.2015.09.032
  25. Lencer R, Mills LJ, Alliey-Rodriguez N, Shafee R, Lee AM, Reilly JL, et al. Genome-wide association studies of smooth pursuit and antisaccade eye movements in psychotic disorders: findings from the BSNIP study. Transl Psychiatry 2017;7:e1249. https://doi.org/10.1038/tp.2017.210
  26. Huttner WB, Gerdes HH, Rosa P. The granin (chromogranin/secretogranin) family. Trends Biochem Sci 1991;16:27-30. https://doi.org/10.1016/0968-0004(91)90012-K
  27. Diaz-Vera J, Morales YG, Hernandez-Fernaud JR, Camacho M, Montesinos MS, Calegari F, et al. Chromogranin B gene ablation reduces the catecholamine cargo and decelerates exocytosis in chromaffin secretory vesicles. J Neurosci 2010;30:950-957. https://doi.org/10.1523/JNEUROSCI.2894-09.2010
  28. Huttner WB, Natori S. Regulated secretion. Helper proteins for neuroendocrine secretion. Curr Biol 1995;5:242-245. https://doi.org/10.1016/S0960-9822(95)00049-2
  29. Gorr SU, Shioi J, Cohn DV. Interaction of calcium with porcine adrenal chromogranin A (secretory protein-I) and chromogranin B (secretogranin I). Am J Physiol 1989;257:E247-E254.
  30. Chanat E, Huttner WB. Milieu-induced, selective aggregation of regulated secretory proteins in the trans-Golgi network. J Cell Biol 1991;115:1505-1519. https://doi.org/10.1083/jcb.115.6.1505
  31. Marksteiner J, Lechner T, Kaufmann WA, Gurka P, Humpel C, Nowakowski C, et al. Distribution of chromogranin B-like immunoreactivity in the human hippocampus and its changes in Alzheimer's disease. Acta Neuropathol 2000;100:205-212. https://doi.org/10.1007/s004010000239
  32. Zhang K, Rao F, Rana BK, Gayen JR, Calegari F, King A, et al. Autonomic function in hypertension; role of genetic variation at the catecholamine storage vesicle protein chromogranin B. Circ Cardiovasc Genet 2009;2:46-56. https://doi.org/10.1161/CIRCGENETICS.108.785659
  33. Kroesen S, Marksteiner J, Leitner B, Hogue-Angeletti R, Fischer-Colbrie R, Winkler H. Rat brain: distribution of immunoreactivity of PE-11, a peptide derived from chromogranin B. Eur J Neurosci 1996;8:2679-2689. https://doi.org/10.1111/j.1460-9568.1996.tb01563.x
  34. Bauer R, Mayr A, Lederer W, Needham PL, Kilpatrick IC, Fleischhacker WW, et al. Further evidence that behavioral tests and neuropeptide mRNA and tissue level alterations can differentiate between typical and atypical antipsychotic drugs. Neuropsychopharmacology 2000;23:46-55. https://doi.org/10.1016/S0893-133X(00)00086-5
  35. Kim JH, Park BL, Pasaje CF, Bae JS, Park CS, Cha B, et al. Lack of associations of neuregulin 1 variations with schizophrenia and smooth pursuit eye movement abnormality in a Korean population. J Mol Neurosci 2012;46:476-482. https://doi.org/10.1007/s12031-011-9619-y
  36. Lee CH, Park BL, Kim LH, Kim DH, Cho SH, Park JS, et al. Relationship between SNP A and P1763 polymorphisms on dystrobrevin binding protein 1 (DTNBP1) gene and smooth pursuit eye movement (SPEM) abnormality in Korean schizophrenic patients. Korean J Biol Psychiatry 2006;13:279-288.
  37. Lee YJ, Lee MK, Kim YJ, Han SW, Hwang J, Kim KH, et al. Association analysis between the G72/G30 single nucleotide polymorphisms (rs947267 and rs77829) and smooth pursuit eye movement (SPEM) abnormalities of patients with schizophrenia in Korean population. Korean J Schzophr Res, 2010;13:42-49.
  38. Pasaje CF, Bae JS, Park BL, Cheong HS, Kim JH, Park TJ, et al. Neuregulin 3 does not confer risk for schizophrenia and smooth pursuit eye movement abnormality in a Korean population. Genes Brain Behav 2011;10:828-833. https://doi.org/10.1111/j.1601-183X.2011.00722.x